Policy Brief Issue 25: South Korea’s Experience of Reimbursing High-Cost Medicines
Cost-effectiveness and availability of alternative treatment options play a crucial role in the listing of new medicines in South Korea. However, high ...Read more
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.